All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| IOVA / Iovance Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
| PCVX / Vaxcyte, Inc.
|
|
|
|
|
|
|
|
| US232109AD04 / Cutera Inc
|
|
|
|
|
|
|
|
| KROS / Keros Therapeutics, Inc.
|
|
|
|
|
|
|
|
| XENE / Xenon Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| OLMA / Olema Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| MLYS / Mineralys Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ARQT / Arcutis Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
| DCPH / Deciphera Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| BMRN / BioMarin Pharmaceutical Inc.
|
|
|
|
|
|
|
|
| BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| AVADEL PHARMACEUTICALS PLC
/ SPONSORED ADR (05337M104) |
|
|
|
|
|
|
|
| GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| KNSA / Kiniksa Pharmaceuticals, Ltd.
|
|
|
|
|
|
|
|
| TRML / Tourmaline Bio, Inc.
|
|
|
|
|
|
|
|
| US46333XAH17 / CONV. NOTE
|
|
|
|
|
|
|
|
| LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| LUNG / Pulmonx Corporation
|
|
|
|
|
|
|
|
| RGEN / Repligen Corporation
|
|
|
|
|
|
|
|
| ADPT / Adaptive Biotechnologies Corporation
|
|
|
|
|
|
|
|
| SRPT / Sarepta Therapeutics, Inc.
|
|
|
|
|
|
|
|
| AKRO / Akero Therapeutics, Inc.
|
|
|
|
|
|
|
|
| US761299AB20 / Retrophin Inc Bond
|
|
|
|
|
|
|
|
| INSP / Inspire Medical Systems, Inc.
|
|
|
|
|
|
|
|
| ISRG / Intuitive Surgical, Inc.
|
|
|
|
|
|
|
|
| CGEM / Cullinan Therapeutics, Inc.
|
|
|
|
|
|
|
|
| LXRX / Lexicon Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ELEV / Elevation Oncology, Inc.
|
|
|
|
|
|
|
|
| US64049MAB63 / NeoGenomics Inc
|
|
|
|
|
|
|
|
| US10806XAB82 / Bridgebio Pharma, Inc.
|
|
|
|
|
|
|
|
| IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| DEXCOM INC
/ NOTE 0.375% 5/1 (252131AM9) |
|
|
|
|
|
|
|
| FDMT / 4D Molecular Therapeutics, Inc.
|
|
|
|
|
|
|
|
| CUTERA INC
/ NOTE 4.000% 6/0 (232109AG3) |
|
|
|
|
|
|
|
| US252131AK39 / CONV. NOTE
|
|
|
|
|
|
|
|
| LXEO / Lexeo Therapeutics, Inc.
|
|
|
|
|
|
|
|
| US670704AJ40 / NuVasive, Inc.
|
|
|
|
|
|
|
|
| KIDS / OrthoPediatrics Corp.
|
|
|
|
|
|
|
|
| RLAY / Relay Therapeutics, Inc.
|
|
|
|
|
|
|
|
| IRWD / Ironwood Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| OM / Outset Medical, Inc.
|
|
|
|
|
|
|
|
| FNA / Paragon 28, Inc.
|
|
|
|
|
|
|
|
| US405024AB67 / Haemonetics Corp
|
|
|
|
|
|
|
|
| US10806XAD49 / BRIDGEBIO PHARMA INC
|
|
|
|
|
|
|
|
| US207410AH48 / CONV. NOTE
|
|
|
|
|
|
|
|
| US803607AD25 / CONV. NOTE
|
|
|
|
|
|
|
|
| US40131MAB54 / CONVERTIBLE ZERO
|
|
|
|
|
|
|
|
| ALEC / Alector, Inc.
|
|
|
|
|
|
|
|
| ETNB / 89bio, Inc.
|
|
|
|
|
|
|
|
| US45784PAK75 / CONV. NOTE
|
|
|
|
|
|
|
|
| EXAS / Exact Sciences Corporation
|
|
|
|
|
|
|
|
| ALGN / Align Technology, Inc.
|
|
|
|
|
|
|
|
| REPL / Replimune Group, Inc.
|
|
|
|
|
|
|
|
| NVCR / NovoCure Limited
|
|
|
|
|
|
|
|
| US02081GAB86 / Alphatec Holdings, Inc.
|
|
|
|
|
|
|
|
| HROW / Harrow, Inc.
|
|
|
|
|
|
|
|
| APLS / Apellis Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ARGX / argenx SE - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| IRTC / iRhythm Technologies, Inc.
|
|
|
|
|
|
|
|
| VKTX / Viking Therapeutics, Inc.
|
|
|
|
|
|
|
|
| GH / Guardant Health, Inc.
|
|
|
|
|
|
|
|
| KRYS / Krystal Biotech, Inc.
|
|
|
|
|
|
|
|
| APGE / Apogee Therapeutics, Inc.
|
|
|
|
|
|
|
|
| NVRO / Nevro Corp.
|
|
|
|
|
|
|
|
| BBIO / BridgeBio Pharma, Inc.
|
|
|
|
|
|
|
|
| AVDL / Avadel Pharmaceuticals plc
|
|
|
|
|
|
|
|
| ITOS / iTeos Therapeutics, Inc.
|
|
|
|
|
|
|
|
| MRVI / Maravai LifeSciences Holdings, Inc.
|
|
|
|
|
|
|
|
| TMDX / TransMedics Group, Inc.
|
|
|
|
|
|
|
|
| SYRE / Spyre Therapeutics, Inc.
|
|
|
|
|
|
|
|
| DAWN / Day One Biopharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| PEN / Penumbra, Inc.
|
|
|
|
|
|
|
|
| CGON / CG Oncology, Inc.
|
|
|
|
|
|
|
|
| CSTL / Castle Biosciences, Inc.
|
|
|
|
|
|
|
|
| LBPH / Longboard Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| KNSA / Kiniksa Pharmaceuticals, Ltd.
|
|
|
|
|
|
|
|
| ARVN / Arvinas, Inc.
|
|
|
|
|
|
|
|
| CELC / Celcuity Inc.
|
|
|
|
|
|
|
|
| TMO / Thermo Fisher Scientific Inc.
|
|
|
|
|
|
|
|
| LIVN / LivaNova PLC
|
|
|
|
|
|
|
|
| OCUL / Ocular Therapeutix, Inc.
|
|
|
|
|
|
|
|
| ATEC / Alphatec Holdings, Inc.
|
|
|
|
|
|
|
|
| NBIX / Neurocrine Biosciences, Inc.
|
|
|
|
|
|
|
|
| DNTH / Dianthus Therapeutics, Inc.
|
|
|
|
|
|
|
|
| SKIN / The Beauty Health Company
|
|
|
|
|
|
|
|
| GKOS / Glaukos Corporation
|
|
|
|
|
|
|
|
